Relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer patients
1. Progression-free and overall survival were greater in relacorilant plus nab-paclitaxel compared to nab-paclitaxel alone. 2. The rate of adverse ...
Tag: platinum-sensitive ovarian epithelial carcinomas
Erlotinib does not demonstrate increased survival in ovarian epithelial carcinomas
Image: PD Sisyphus 1. Patients with previously platinum-sensitive ovarian cancer showed no increase in progression-free survival or overall survival when ...
